A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)

This study has been completed.

Study NCT00216489 Information provided by Janssen Cilag Pharmaceutica S.A.C.I., Greece

First Received: September 13, 2005 Last Updated: April 22, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2005
Estimated Primary Completion Date:	No date given